Traditional Chinese medicine composition for treating bronchiectasia

Abstract

The invention discloses a traditional Chinese medicine composition for treating bronchiectasia. The traditional Chinese medicine composition for treating bronchiectasia comprises the following raw materials in parts by weight: 5-7 parts of prepared rehmannia root, 3-5 parts of seeds of Chinese waxgourd, 2-4 parts of caulis perllae, 5.5-7.5 parts of medicated leaven, 2-4 parts of semen lepidii, 10-12 parts of cassia twig, 4-6 parts of aloe, 3-5 parts of honey-fried licorice root, 2-4 parts of ephedra, 1-3 parts of flos farfarae, 4-6 parts of the root bark of white mulberry, 5-7 parts of radix bupleuri, 3-5 parts of cortex lycii radicis, 2-4 parts of cacumen biotae, 4-6 parts of golden cypress, 5-7 parts of schisandra chinensis, 1-3 parts of schisandra propinqua, 2-4 parts of scutellaria barbata, 1-3 parts of callicarpa longissima, 2-4 parts of sedum sarmentosum, 1-3 parts of bermuda grass and 2-4 parts of root of Japanese raspberry. The traditional Chinese medicine composition disclosed by the invention has the functions of relieving exterior syndromes, clearing heat, invigorating qi, strengthening spleen, eliminating dampness, alleviating water retention, purging intense heat, reducing phlegm, moistening lung and arresting cough, and the like, and has good curative effect on bronchiectasia, can take effect quickly, and is free of any toxic and side effects and high in cure rate which is up to 99%.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating bronchiectasis, belonging to the field of traditional Chinese medicine. Background technique [0002] Bronchiectasis refers to the irreversible dilation of the proximal medium-sized bronchi due to the destruction of the muscular and elastic components of the tube wall. It is a chronic purulent lung disease. Most of the disease is acquired, more common in children and young adults. Most of them are secondary to acute and chronic respiratory tract infections and bronchial obstruction. Most of the patients have a history of childhood measles, whooping cough or bronchopneumonia. The clinical manifestations are mainly chronic cough, coughing up a large amount of purulent sputum and repeated hemoptysis. At present, the clinical treatment of bronchiectasis To anti-inflammatory, phlegm, asthma-based, or surgical resection, the effect is not ideal. SUMMARY OF THE INVENTION [0...

AI Technical Summary

Problems solved by technology

Most of them are secondary to acute or chronic respiratory infection and bronchial obstruction, and most patients have a history of childhood measles, whooping cough or bronchial pneumonia; the clinical manifestations are mainly chronic cough, coughing up a large amount of purulent sputum and repeated hemoptysis; currently, the clinical treatment of bronchiectasis Anti-inflammatory, phlegm-reducing, asthma-relieving, or surgical resection, the effect is not satisfactory